Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SGX:1J5's Forward Dividend Yield % is ranked better than 71.43% of 70
companies
in the Medical Distribution industry
Industry Median: 2.89
vs SGX:1J5: 4.17
During the past 3 years, the average Dividends Per Share Growth Rate was 28.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 11.10% per year.
During the past 11 years, the highest 3-Year average Dividends Per Share Growth Rate of Hyphens Pharma International was 28.90% per year. The lowest was 3.20% per year. And the median was 9.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Hyphens Pharma International (SGX:1J5) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Hyphens Pharma International Forward Dividend Yield % Related Terms
SGX:1J5 vs MCK, COR, CAH: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, Hyphens Pharma International's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyphens Pharma International Forward Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hyphens Pharma International's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Hyphens Pharma International's Forward Dividend Yield % falls into.
Hyphens Pharma International Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Hyphens Pharma International Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
SGD 0.015000
2026-05-06
2026-05-08
2026-05-22
Cash Dividend
annually
SGD:SGD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 4.17% mean?
Hyphens Pharma International (SGX:1J5) has a Forward Dividend Yield % of 4.17% as of Sep. 07, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Hyphens Pharma International and its competitors. According to the industry distribution chart, Hyphens Pharma International ranks #20 out of 70 companies in the Medical Distribution industry, placing it in the top 28.6%.
Is Hyphens Pharma International's Forward Dividend Yield % too high?
Hyphens Pharma International's current Forward Dividend Yield % is 4.17%. The Medical Distribution industry median Forward Dividend Yield % is 2.89. Hyphens Pharma International's value of 4.17% is 44.3% above this industry median. Based on the distribution chart, Hyphens Pharma International ranks #20 out of 70 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Hyphens Pharma International has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hyphens Pharma International's Forward Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hyphens Pharma International ranks #20 out of 70 companies for Forward Dividend Yield %. This puts Hyphens Pharma International in the upper half of its industry. The industry median Forward Dividend Yield % is 2.89. Hyphens Pharma International's value of 4.17% is 44.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.89, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hyphens Pharma International's current Forward Dividend Yield % of 4.17% is 44.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Hyphens Pharma International and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyphens Pharma International's current Forward Dividend Yield % is 4.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyphens Pharma International stock overvalued right now?
Based on GuruFocus' analysis, Hyphens Pharma International (SGX:1J5) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.31, compared to a current price of S$0.36 — trading 16.1% above its estimated fair value. The current Forward Dividend Yield % is 4.17% and 44.3% above the Medical Distribution industry median of 2.89. Hyphens Pharma International's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Hyphens Pharma International (SGX:1J5), the current Forward Dividend Yield % is 4.17% as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyphens Pharma International (SGX:1J5) Overvalued in 2026?
Based on GuruFocus' analysis, Hyphens Pharma International stock appears to be overvalued.
The current stock price of S$0.36 is trading 16.1% above its estimated GF Value™ of S$0.31.
GuruFocus considers Hyphens Pharma International to be Modestly Overvalued.
Key valuation signals for SGX:1J5:
Forward Dividend Yield %: 4.17%
GF Value™: S$0.31 vs. price of S$0.36 (16.1% above fair value)
Industry Position: 44.3% above the Medical Distribution median (#20 of 70)
No single metric tells the full story. See the SGX:1J5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
82GF Score
Get the complete analysis for SGX:1J5
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1J5 has been successfully added to your 
